Current strategies and novel immunotherapeutic approaches for overcoming immune resistance in glioblastoma

Abstract Glioblastoma (GBM) is the most aggressive primary malignant brain tumor, characterized by rapid proliferation, extensive invasion, and significant genetic heterogeneity. Despite the availability of standard treatments such as surgical resection, radiotherapy, and chemotherapy, the prognosis...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Mehrdad Nourizadeh, Saeid Mohammadzadeh Mounesyar, Mahdi Salimi Movahhed, Kasra Alipour, Rozhan Zekavatbakhsh, Mobina Hoseinzadeh, Shaghayegh Davari, Mehdi Amirhooshangi, Hadi Amirhoushangi, Sina Hamzehzadeh
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer 2025-10-01
סדרה:	Discover Oncology
נושאים:	Glioblastoma Immunotherapy Gene editing Nanoparticles CAR-T Exosomes
גישה מקוונת:	https://doi.org/10.1007/s12672-025-03807-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!